Breeze /
YD Biopharma
Breeze Holdings Acquisition Corp. combines with YD Biopharma Limited
Source for the buyer and target: Breeze Holdings Acquisition Corp.
For the buyer and target.
“Pursuant to the terms of the Merger Agreement, Breeze Merger Sub will merge with and into Breeze with Breeze surviving the merger as a wholly owned subsidiary of Pubco (the “Breeze Merger”), and Company Merger Sub will merge with and into YD Biopharma, with YD Biopharma surviving such merger as a wholly owned subsidiary of Pubco (the “Company Merger” and together with the Breeze Merger, the “Mergers” and together with the other transactions and ancillary agreements contemplated by the Merger Agreement, the “Business Combination”).”
Published 21 Jul 2025
Open the sourceWhat happened
Breeze and YD Biopharma Limited entered into a merger agreement for a business combination involving YD Bio Limited and merger subsidiaries. The merger agreement sets an equity value of $647,304,110 for YD Biopharma's equity holders. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Breeze Holdings Acquisition Corp. combines with YD Biopharma Limited
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly